Pregled bibliografske jedinice broj: 1178330
The Outcome of Radioiodine Therapy for Graves’ Hyperthyroidism: a Single Institution Experience with Calculated Dose Regimen
The Outcome of Radioiodine Therapy for Graves’ Hyperthyroidism: a Single Institution Experience with Calculated Dose Regimen // European Journal of Nuclear Medicine and Molecular Imaging (2018) 45 (Suppl 1)
Düsseldorf, Njemačka: Springer, 2018. str. 114-115 (poster, podatak o recenziji nije dostupan, kratko priopćenje, stručni)
CROSBI ID: 1178330 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Outcome of Radioiodine Therapy for Graves’
Hyperthyroidism: a Single Institution Experience
with Calculated Dose Regimen
Autori
Jukić, Tomislav ; Punda, Marija ; Vidranski, Valentina ; Franceschi, Maja ; Kusić, Zvonko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, kratko priopćenje, stručni
Izvornik
European Journal of Nuclear Medicine and Molecular Imaging (2018) 45 (Suppl 1)
/ - : Springer, 2018, 114-115
Skup
Annual Congress of the European Association of Nuclear Medicine (EANM)
Mjesto i datum
Düsseldorf, Njemačka, 13.10.2018. - 17.10.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
I-131 therapy, Graves’ hyperthyroidism
Sažetak
S: Iodine-131 therapy is effective treatment of GH. In pts with lower TGW (<20g), with this calculated dose approach, 100% cure rate was achieved with one RAIT. However, for larger glands, more than one RAIT was necessary to cure hyperthyroidism, especially for TGW>40g. Therefore, for large glands, ablative approach with 5, 92 -7, 4 MBq I-131/g of TGW should be advocated. No difference in median TGW decrease was observed between groups probably due to calculated approach
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Marija Punda
(autor)
Tomislav Jukić
(autor)
Maja Franceschi
(autor)
Valentina Vidranski
(autor)
Zvonko Kusić
(autor)